These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31279770)

  • 1. Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program.
    Martin RA; Gresko SA; Brinkley-Rubinstein L; Stein LAR; Clarke JG
    Prev Med; 2019 Nov; 128():105766. PubMed ID: 31279770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting.
    Brinkley-Rubinstein L; Peterson M; Clarke J; Macmadu A; Truong A; Pognon K; Parker M; Marshall BDL; Green T; Martin R; Stein L; Rich JD
    Drug Alcohol Depend; 2019 Dec; 205():107514. PubMed ID: 31614328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration.
    Kaplowitz E; Truong A; Macmadu A; Berk J; Martin H; Burke C; Rich JD; Brinkley-Rubinstein L
    J Addict Med; 2023 Jan-Feb 01; 17(1):54-59. PubMed ID: 35916404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island.
    Peterson M; Macmadu A; Truong AQ; Rich J; Pognon K; Lurie M; Clarke JG; Brinkley-Rubinstein L
    J Subst Abuse Treat; 2019 Nov; 106():73-78. PubMed ID: 31540614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
    Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
    Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
    [No Abstract]   [Full Text] [Related]  

  • 10. "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.
    Maradiaga JA; Nahvi S; Cunningham CO; Sanchez J; Fox AD
    J Subst Abuse Treat; 2016 Mar; 62():49-54. PubMed ID: 26747509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Self-Efficacy on Treatment.
    Franckowiak BA; Glick DF
    J Addict Nurs; 2015; 26(2):62-70. PubMed ID: 26053078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
    McElrath K
    Subst Use Misuse; 2018 Jan; 53(2):334-343. PubMed ID: 28862903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release naltrexone for opioid use disorder started during or following incarceration.
    Lincoln T; Johnson BD; McCarthy P; Alexander E
    J Subst Abuse Treat; 2018 Feb; 85():97-100. PubMed ID: 28479011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of buprenorphine during incarceration and retention in treatment upon release.
    Zaller N; McKenzie M; Friedmann PD; Green TC; McGowan S; Rich JD
    J Subst Abuse Treat; 2013 Aug; 45(2):222-6. PubMed ID: 23541303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program.
    Kaucher KA; Caruso EH; Sungar G; Gawenus L; Hurlbut K; Sanchez DC; Broderick K
    Am J Emerg Med; 2020 Feb; 38(2):300-304. PubMed ID: 31387811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
    Friedmann PD; Hoskinson R; Gordon M; Schwartz R; Kinlock T; Knight K; Flynn PM; Welsh WN; Stein LA; Sacks S; O'Connell DJ; Knudsen HK; Shafer MS; Hall E; Frisman LK;
    Subst Abus; 2012; 33(1):9-18. PubMed ID: 22263709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.
    Gordon MS; Vocci FJ; Fitzgerald TT; O'Grady KE; O'Brien CP
    Contemp Clin Trials; 2017 Feb; 53():130-136. PubMed ID: 28011389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Assisted Treatment Program Policies: Opinions of People in Treatment.
    Carter M; Boyd J; Bennett T; Baus A
    J Prim Care Community Health; 2023; 14():21501319231195606. PubMed ID: 37635696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.